Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease

被引:59
作者
Leung, Christopher [1 ,2 ]
Herath, Chandana B. [1 ]
Jia, Zhiyuan [1 ]
Andrikopoulos, Sof [1 ]
Brown, Bronwyn E. [3 ]
Davies, Michael J. [3 ]
Rivera, Leni R. [4 ,5 ]
Furness, John B. [4 ]
Forbes, Josephine M. [6 ]
Angus, Peter W. [1 ,2 ]
机构
[1] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic 3084, Australia
[2] Austin Hosp, Austin Hlth, Dept Gastroenterol & Hepatol, Melbourne, Vic 3084, Australia
[3] Heart Res Inst, Newtown, NSW 2042, Australia
[4] Univ Melbourne, Parkville, Vic 3052, Australia
[5] Deakin Univ, Metab Res Unit, Sch Med, Geelong, Vic 3216, Australia
[6] Mater Med Res Inst, Glycat & Diabet Complicat Grp, South Brisbane, Qld 4101, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Advanced glycation end-products; Fructose; Steatohepatitis; Non-alcoholic fatty liver disease; Hepatic fibrosis; Oxidative stress; HEPATIC STELLATE CELLS; NADPH OXIDASE; OXIDATIVE STRESS; ANIMAL-MODELS; RECEPTOR; FIBROSIS; MICE; STEATOHEPATITIS; PROGRESSION; ENDPRODUCTS;
D O I
10.3748/wjg.v22.i35.8026
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To determine if manipulation of dietary advanced glycation end product (AGE), intake affects nonalcoholic fatty liver disease (NAFLD) progression and whether these effects are mediated via RAGE. METHODS Male C57Bl6 mice were fed a high fat, high fructose, high cholesterol (HFHC) diet for 33 wk and compared with animals on normal chow. A third group were given a HFHC diet that was high in AGEs. Another group was given a HFHC diet that was marinated in vinegar to prevent the formation of AGEs. In a second experiment, RAGE KO animals were fed a HFHC diet or a high AGE HFHC diet and compared with wildtype controls. Hepatic biochemistry, histology, picrosirius red morphometry and hepatic mRNA were determined. RESULTS Long-term consumption of the HFHC diet generated significant steatohepatitis and fibrosis after 33 wk. In this model, hepatic 4-hydroxynonenal content (a marker of chronic oxidative stress), hepatocyte ballooning, picrosirius red staining, alpha-smooth muscle actin and collagen type 1A gene expression were all significantly increased. Increasing the AGE content of the HFHC diet by baking further increased these markers of liver damage, but this was abrogated by pre-marination in acetic acid. In response to the HFHC diet, RAGE(-/-) animals developed NASH of similar severity to RAGE(+/+) animals but were protected from the additional harmful effects of the high AGE containing diet. Studies in isolated Kupffer cells showed that AGEs increase cell proliferation and oxidative stress, providing a likely mechanism through which these compounds contribute to liver injury. CONCLUSION In the HFHC model of NAFLD, manipulation of dietary AGEs modulates liver injury, inflammation, and liver fibrosis via a RAGE dependent pathway. This suggests that pharmacological and dietary strategies targeting the AGE/RAGE pathway could slow the progression of NAFLD.
引用
收藏
页码:8026 / 8040
页数:15
相关论文
共 50 条
  • [21] Preclinical models of non-alcoholic fatty liver disease
    Santhekadur, Prasanna K.
    Kumar, Divya P.
    Sanyal, Arun J.
    JOURNAL OF HEPATOLOGY, 2018, 68 (02) : 230 - 237
  • [22] Non-alcoholic fatty liver disease: pathogenesis and models
    Zhong, Hanxiang
    Dong, Jiayong
    Zhu, Liye
    Mao, Jiaxi
    Dong, Junfeng
    Zhao, Yuanyu
    Zou, You
    Guo, Meng
    Ding, Guoshan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (02): : 387 - 399
  • [23] Role of Leptin in Non-Alcoholic Fatty Liver Disease
    Jimenez-Cortegana, Carlos
    Garcia-Galey, Alba
    Tami, Malika
    del Pino, Pilar
    Carmona, Isabel
    Lopez, Soledad
    Alba, Gonzalo
    Sanchez-Margalet, Victor
    BIOMEDICINES, 2021, 9 (07)
  • [24] Coronavirus disease 2019 and non-alcoholic fatty liver disease
    Bellanti, Francesco
    Vendemiale, Gianluigi
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (09) : 969 - 978
  • [25] Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease
    Nababan, Saut Horas H.
    Nishiumi, Shin
    Kawano, Yuki
    Kobayashi, Takashi
    Yoshida, Masaru
    Azuma, Takeshi
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2017, 623 : 64 - 75
  • [26] Effect of Dietary Advanced Glycation End Products on Mouse Liver
    Patel, Raza
    Baker, Susan S.
    Liu, Wensheng
    Desai, Sonal
    Alkhouri, Razan
    Kozielski, Rafal
    Mastrandrea, Lucy
    Sarfraz, Adil
    Cai, Weijing
    Vlassara, Helen
    Patel, Mulchand S.
    Baker, Robert D.
    Zhu, Lixin
    PLOS ONE, 2012, 7 (04):
  • [27] Pathogenesis of non-alcoholic fatty liver disease
    Anty, Rodolphe
    Gual, Philippe
    PRESSE MEDICALE, 2019, 48 (12): : 1468 - 1483
  • [28] Mitochondria in non-alcoholic fatty liver disease
    Simoes, Ines C. M.
    Fontes, Adriana
    Pinton, Paolo
    Zischka, Hans
    Wieckowski, Mariusz R.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 95 : 93 - 99
  • [29] Treatment of Non-Alcoholic Fatty Liver Disease
    Scherer, Antonia
    Dufour, Jean-Francois
    DIGESTIVE DISEASES, 2016, 34 : 27 - 31
  • [30] Non-alcoholic fatty liver disease in pregnancy
    Benson, Charlotte S.
    Cobbold, Jeremy F.
    Frise, Charlotte J.
    OBSTETRIC MEDICINE, 2023, 16 (02) : 116 - 119